Sarepta Therapeutics reported $9K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Avrobio Inc AVRO:US USD 4K 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Daiichi Sankyo 4568:JP JPY 50B 0
Esperion Therapeutics ESPR:US USD 75K 3K
Insmed INSM:US USD 1.36M 140K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
IONIS PHARMACEUT IONS:US USD 142K 0
Mirati Therapeutics MRTX:US USD 58K 0
Moderna Inc MRNA:US USD 38.5K 200
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Newlink Genetics NLNK:US USD 82K 1000
Novavax NVAX:US USD 868K 76K
Ptc Therapeutics PTCT:US USD 72K 1000
Roche Holding ROG:VX 107M 0
Sangamo Biosciences SGMO:US USD 1.67M 49K
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
YTE INCY:US USD 223K 1000